Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new revision of the study record.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a change in the ClinicalTrials.gov page build rather than the underlying study record.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision label updated to v3.5.0 on the page, replacing the previous v3.4.3.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check110 days agoChange DetectedRevision: v3.4.2 was added and the funding-status notice (along with the v3.4.1 note) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.